Literature DB >> 4952730

Conversion of chronic atrial fibrillation to sinus rhythm with combined propranolol and quinidine treatment.

S Stern.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4952730     DOI: 10.1016/0002-8703(67)90274-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  10 in total

1.  [Drug therapy of tachyarrhythmias (author's transl)].

Authors:  K Theisen
Journal:  Klin Wochenschr       Date:  1978-02-15

2.  Beta-blocking agents in cardiac arrhythmias.

Authors:  R Starcich
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

3.  Is quinidine outdated?

Authors: 
Journal:  Br Med J       Date:  1969-02-08

4.  Cardioversion with flecainide in patients with atrial fibrillation of recent onset.

Authors:  J J Goy; R Maendly; M Grbic; L Finci; U Sigwart
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Treatment and prevention of cardiac arrhythmias with propranolol and quinidine.

Authors:  S Stern
Journal:  Br Heart J       Date:  1971-07

Review 6.  The pharmacologic treatment of atrial fibrillation.

Authors:  R Bolognesi
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 7.  Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.

Authors:  D T Mason; A N DeMaria; E A Amsterdam; R Zelis; R A Massumi
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 8.  Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.

Authors:  B N Singh; D E Jewitt
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 9.  Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

Authors:  Giuseppe Boriani; Igor Diemberger; Mauro Biffi; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Quinidine for pharmacological cardioversion of atrial fibrillation: a retrospective analysis in 501 consecutive patients.

Authors:  Bernhard Schwaab; Alexander Katalinic; Uta Maria Böge; Jürgen Loh; Peter Blank; Tatjana Kölzow; Dirk Poppe; Hendrik Bonnemeier
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-04       Impact factor: 1.468

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.